Bath & Body Works logged a 2.3% change during today's morning session, and is now trading at a price of $46.72 per share.
Bath & Body Works returned gains of 16.1% last year, with its stock price reaching a high of $48.43 and a low of $27.3. Over the same period, the stock underperformed the S&P 500 index by -10.8%. The company's 50-day average price was $43.98. Bath & Body Works, Inc. operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. The Large-Cap Consumer Cyclical company is based in Columbus, OH. Bath & Body Works has not offered a dividend during the last year.
The Company's Revenues Are Declining:
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Revenue (M) | $12,632 | $13,237 | $5,405 | $6,434 | $7,882 | $7,560 |
| Gross Margins | 39% | 37% | 44% | 48% | 49% | 43% |
| Net Margins | 8% | 5% | -7% | 13% | 17% | 11% |
| Net Income (M) | $983 | $644 | -$366 | $844 | $1,333 | $794 |
| Net Interest Expense (M) | $406 | $385 | $370 | $432 | $388 | -$348 |
| Diluted Shares (M) | 275 | 276 | 283 | 267 | 229 | 228 |
| Earnings Per Share | $3.42 | $2.31 | -$1.32 | $3.0 | $4.88 | $3.43 |
| EPS Growth | n/a | -32.46% | -157.14% | 327.27% | 62.67% | -29.71% |
| Avg. Price | $25.22 | $17.01 | $18.55 | $55.89 | $46.65 | $46.305 |
| P/E Ratio | 7.29 | 7.3 | -13.95 | 18.38 | 9.41 | 13.5 |
| CAPEX (M) | $707 | $629 | $458 | $228 | $270 | $328 |
| Total Debt (M) | $5,763 | $5,814 | $6,375 | $4,852 | $4,860 | $4,497 |
| Current Ratio | 1.37 | 1.15 | 1.48 | 2.08 | 1.34 | 1.39 |
Bath & Body Works Is Overvalued:
Bath & Body Works has a trailing twelve month P/E ratio of 11.5, compared to an average of 22.96 for the Consumer Cyclical sector. Based on its EPS guidance of $3.72, the company has a forward P/E ratio of 11.8. The 1.2% compound average growth rate of Bath & Body Works's historical and projected earnings per share yields a PEG ratio of 9.48. This suggests that these shares are overvalued.
There's an Analyst Consensus of Some Upside Potential for Bath & Body Works:
The 18 analysts following Bath & Body Works have set target prices ranging from $30.0 to $60.0 per share, for an average of $48.42 with a buy rating. The company is trading -3.5% away from its average target price, indicating that there is an analyst consensus of some upside potential.
Bath & Body Works has an average amount of shares sold short because 3.7% of the company's shares are sold short. Institutions own 97.4% of the company's shares, and the insider ownership rate stands at 0.43%, suggesting a small amount of insider investors. The largest shareholder is Vanguard Group Inc, whose 12% stake in the company is worth $1,228,552,329.
